Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


suck pdf from google scholar
unlimited free pdf from europmc34861051    free
PDF from PMC    free
html from PMC    free
PDF vom PMID34861051  :  Publisher
PDF vom PMID34861051

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • High CD4-to-CD8 ratio identifies an at-risk population susceptible to lethal COVID-19 #MMPMID34861051
  • De Zuani M; Laznickova P; Tomaskova V; Dvoncova M; Forte G; Stokin GB; Sramek V; Helan M; Fric J
  • Scand J Immunol 2022[Mar]; 95 (3): e13125 PMID34861051show ga
  • Around half of people with severe COVID-19 requiring intensive care unit (ICU) treatment will survive, but it is unclear how the immune response to SARS-CoV-2 differs between ICU patients that recover and those that do not. We conducted whole-blood immunophenotyping of COVID-19 patients upon admission to ICU and during their treatment and uncovered marked differences in their circulating immune cell subsets. At admission, patients who later succumbed to COVID-19 had significantly lower frequencies of all memory CD8+ T cell subsets, resulting in increased CD4-to-CD8 T cell and neutrophil-to-CD8 T cell ratios. ROC and Kaplan-Meier analyses demonstrated that both CD4-to-CD8 and neutrophil-to-CD8 ratios at admission were strong predictors of in-ICU mortality. Therefore, we propose the use of the CD4-to-CD8 T cell ratio as a marker for the early identification of those individuals likely to require enhanced monitoring and/or pro-active intervention in ICU.
  • |Aged[MESH]
  • |CD4-CD8 Ratio/methods[MESH]
  • |CD4-Positive T-Lymphocytes/*immunology[MESH]
  • |CD8-Positive T-Lymphocytes/*immunology[MESH]
  • |COVID-19/*immunology[MESH]
  • |Female[MESH]
  • |Humans[MESH]
  • |Immunophenotyping/methods[MESH]
  • |Intensive Care Units[MESH]
  • |Lymphocyte Count/methods[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Prospective Studies[MESH]
  • |SARS-CoV-2/immunology[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    e13125 3.95 2022